Doctrina Raises €1,020,000 of New Capital

Doctrina, a start-up company transforming the traditional transfer of knowledge between pharmaceutical companies and pharmacies, has raised a total of €1,020,000 in series A funding. The investment will enable Doctrina to execute its growth plans and scale its solution to new markets.

"We are excited to receive the new capital from our investors," says Tomaž Erjavec, founder and managing partner of Doctrina. "Our goal is to make Doctrina an indispensable part of pharmacists' workdays with the mission to optimize the transfer of knowledge and patient safety."

Doctrina helps pharmacists to access knowledge about new pharmaceutical products and other professional novelties on one independent platform. Due to the amount of products each pharmacy offers, it's impossible for the employees of the pharmacies to keep track of all changes and innovations. Based on the fact that 87% of healthcare professionals conclude contact with a pharmaceutical sales rep in less than two minutes and that sales reps spend 50% of their working time in their cars, Doctrina has developed a signature technology that enables pharmaceutical companies to achieve greater reach, faster knowledge delivery with real-time feedback, and more efficient two-way communication. The method used to further train the pharmacists has been developed with the latest e-learning trends and is available in a video micro-learning format. This helps pharmacists and pharmaceutical technicians to access knowledge about products and all content in one place, anytime and on any device.

A substantial portion of investment will be used to execute the company's growth plans, which are focused on Poland and the UK, as well as some other smaller markets, but will also focus on further product development, and the expansion of the international team.

"Our platform is already used by 55,000 pharmacists from Poland, Russia, Slovenia, Romania and Croatia. The plan is to now bring our technology to other countries in Europe and enable pharmaceutical companies and pharmacists to increase the flow of effective knowledge transfer. We are also focusing on finding digital health enthusiasts to join our international team working on multiple markets." commented Jure Pučko, CEO and founder of Doctrina. "Our vision is to make Doctrina an indispensable daily source of product news and other professional information."

For further information, please visit:
https://en.doctrina.biz

About Doctrina
Doctrina is an online platform that allows pharmaceutical companies to further train pharmacy employees through webinars. It assists sales representative visits with greater and faster reach, lower costs, and accurate analytics. The platform is used daily by over 55,000 pharmacists from Slovenia, Romania, Poland, Russia and Croatia.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...